CMG Pharmaceutical Co. Ltd (058820) — Capital Reinvestment Ratio
CMG Pharmaceutical Co. Ltd (058820) has a Capital Reinvestment Ratio of 109.44x as of December 2024, meaning it reinvests 109% of its operating cash flow (₩290.09 Million) in capital expenditures (₩31.75 Billion). See net asset quality index of CMG Pharmaceutical Co. Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CMG Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks CMG Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Check CMG Pharmaceutical Co. Ltd (058820) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for CMG Pharmaceutical Co. Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for CMG Pharmaceutical Co. Ltd from 2014 to 2024. For live market cap and broader valuation context, see CMG Pharmaceutical Co. Ltd (058820) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 109.44x | ₩290.09 Million | ₩31.75 Billion | ▲ +2706.1% |
| 2023 | 3.90x | ₩3.91 Billion | ₩15.25 Billion | ▲ +86.8% |
| 2022 | 2.09x | ₩4.94 Billion | ₩10.31 Billion | ▲ +197.4% |
| 2021 | 0.70x | ₩5.63 Billion | ₩3.95 Billion | ▼ -78.6% |
| 2020 | 3.28x | ₩2.94 Billion | ₩9.65 Billion | ▲ +13.2% |
| 2019 | 2.90x | ₩2.82 Billion | ₩8.18 Billion | ▲ +0.9% |
| 2018 | 2.87x | ₩886.78 Million | ₩2.55 Billion | ▲ +635.3% |
| 2017 | 0.39x | ₩1.95 Billion | ₩760.59 Million | ▲ +12.8% |
| 2016 | 0.35x | ₩2.31 Billion | ₩799.00 Million | ▼ -77.0% |
| 2015 | 1.51x | ₩2.41 Billion | ₩3.64 Billion | ▼ -88.4% |
| 2014 | 13.00x | ₩724.89 Million | ₩9.42 Billion | — |